Jeong-Hoon Lee focuses his practice on capital markets, corporate finance, acquisition finance, general finance, shipping/aircraft finance, project finance, and private equity investment.
Mr. Lee played a leading role in advising K Car, Kakaopay, HK inno.N, SD Biosensor, DoubleDown Interactive, SK Biopharmaceuticals, Big Hit Entertainment, Samsung Life Insurance, and Netmarble on their IPO; Samhwa Paints Industrial on its CB issuance; Woori Bank on its mezzanine investments, including establishing New Growth Company Fund and investing in venture firms and startups; a number of clients on their aircraft finance, as in the case of, e.g., the financing for Sichuan MSN 1528; financing of SK Siltron's acquisition of an overseas wafer business division; and facility loans of Lotte Versalis Elastomers.
Mr. Lee graduated from the Department of Law of Seoul National University, completed the 34th Judicial Research and Training Institute course, and earned his LL.M. from Santa Clara University School of Law.
Awards and Recognition
Related ContentView more
Recent WorksBKL Advises on SK hynix’s Global Offering of US$1.7 Billion 1.75% Convertible Bonds due 2030- Capital Markets2023-04-13
NewslettersSTRENGTHENING THE PROTECTION OF SHAREHOLDERS IN CASE OF CHANGES IN CORPORATE OWNERSHIP STRUCTURE SUCH AS SPLIT-OFFS, ETC. - REVISION OF THE CORPORATE GOVERNANCE REPORT GUIDELINES- BKL Legal Update2022-03-11
Recent WorksBKL Advises on LG Energy Solution’s IPO- Capital Markets2022-01-28
Recent WorksBKL Advises on Kakaopay’s Korean IPO on KOSPI- Capital Markets2021-11-05
Recent WorksBKL Advises on K Car’s IPO on KOSPI- Capital Markets2021-10-20
Recent WorksBKL Advises on DoubleDown Interactive’s NASDAQ IPO- Capital Markets2021-09-07
Recent WorksBKL Advises on HK inno.N’s Korean IPO on KOSDAQ- Capital Markets2021-08-10
Recent WorksBKL Advises on Big Hit Entertainment IPO- Capital Markets2020-10-16
Recent WorksBKL Advises on SK Biopharm’s IPO- Capital Markets2020-07-09
Recent WorksBKL Advised SK hynix on its issuance of US$500,000,000 3.000% Notes due 2024- Capital Markets2019-10-07